An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Material Removal
According to TikTok, the platform has taken down problematic material and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.
Within minutes of joining one group, a vendor posted contact information, where the majority of transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Information and Costs
Inside these communities, messages show dark colored packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service said it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.
